Zobrazeno 1 - 10 of 93 pro vyhledávání: '"Alessia, Bari"'
3
Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature
Autor: Fabio Gelsomino, Samantha Pozzi, Alessia Bari, Francesco Caputo, Massimo Dominici, Krisida Cerma, Martina Fanelli
Publikováno v: Journal of Oncology Pharmacy Practice. 27:766-770
Introduction Pazopanib, a tyrosine kinase inhibitor (TKI), is a standard treatment for various tumours, including metastatic non-adipocytic soft-tissue sarcomas. In literature, erythrocytosis has been described as a TKI-related condition. Case report
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b33f7d9b9df2708c1873ee11bcfb8154
https://doi.org/10.1177/1078155220950440
Zobrazit plný text záznamu
5
Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma. A Systematic Review by the Fondazione Italiana Linfomi
Autor: Luca Nassi, Vitaliana De Sanctis, Giacomo Loseto, Chiara Gerardi, Eleonora Allocati, Sabino Ciavarella, Carla Minoia, Attilio Guarini, Alessia Bari
Publikováno v: Cancers, Vol 14, Iss 519, p 519 (2022)
Background: The increase of lymphoma patient survival led to a modification of the incidence of long-term sequelae, including second malignancies (SM). Several groups have dealt with the incidence of SM, according to the primary treatment; however, a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7a92dae2c07e350e91863824e39ae2
https://hdl.handle.net/11380/1264808
Zobrazit plný text záznamu
7
The Impact of Healthy Lifestyles on Late Sequelae in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors. A Systematic Review by the Fondazione Italiana Linfomi
Autor: Eleonora Allocati, Attilio Guarini, Carla Minoia, Chiara Gerardi, Vitaliana De Sanctis, Antonella Daniele, Alessia Bari
Publikováno v: Cancers
Cancers, Vol 13, Iss 3135, p 3135 (2021)
Simple Summary With the presented study, Fondazione Italiana Linfomi (FIL) researchers want to fill a gap in the literature regarding long-lived lymphoma patients (beyond 5 years after diagnosis). These patients can develop a series of late sequelae
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a49febf79a1765639e8e75de9d521f3
http://europepmc.org/articles/PMC8268176
Zobrazit plný text záznamu
10
Akademický článek
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era
Autor: Tamar Tadmor, Alessia Bari, Stefano Sacchi, Luigi Marcheselli, Eliana Valentina Liardo, Irit Avivi, Noam Benyamini, Dina Attias, Samantha Pozzi, Maria Christina Cox, Luca Baldini, Maura Brugiatelli, Massimo Federico, Aaron Polliack
Publikováno v: Haematologica, Vol 99, Iss 1 (2014)
In this study we assessed the prognostic significance of absolute monocyte count and selected the best cut-off value at diagnosis in a large cohort of patients with diffuse large B-cell lymphoma. Data were retrieved for therapy-naïve patients with d
Externí odkaz: https://doaj.org/article/1d318177f13e4479ac8436fd14aaec54
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje